Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma
Dreyling, M., Morschhauser, F., Bouabdallah, K., Bron, D., Cunningham, D., Assouline, S.E., Verhoef, G., Linton, K., Thieblemont, C., Vitolo, U., Hiemeyer, F., Giurescu, M., Garcia-Vargas, J., Gorbatchevsky, I., Liu, L., Koechert, K., Peña, C., Neves, M., Childs, B.H., Zinzani, P.L.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
PI3K inhibition and modulation of immune and tumor microenvironment markers by copanlisib in patients with non-Hodgkin's lymphoma or advanced solid tumors
Awada, A.H., Morschhauser, F., Machiels, J.-P., Salles, G., Rottey, S., Rule, S., Cunningham, D., Peyrade, F., Fruchart, C., Arkenau, H.-T., Genvresse, I., Koechert, K., Cisternas, G., Granvil, C., Pena, C., Liu, L.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
PD-003Analysis of single-nucleotide polymorphisms (SNPs) in the phase 3 CORRECT trial of regorafenib vs placebo in patients with metastatic colorectal cancer (mCRC)
Lambrechts, D, Koechert, K, Schulz, A, Vonk, R, Rutstein, M, Kobina, S, Grothey, A, Van Cutsem, E, Teufel, M
Published in Annals of oncology (01.06.2016)
Published in Annals of oncology (01.06.2016)
Get full text
Journal Article
High-level expression of Mastermind-like 2 contributes to aberrant activation of the NOTCH signaling pathway in human lymphomas
KÖCHERT, K, ULLRICH, K, STEIN, H, JANZ, M, DÖRKEN, B, MATHAS, S, KREHER, S, ASTER, J. C, KITAGAWA, M, JÖHRENS, K, ANAGNOSTOPOULOS, I, JUNDT, F, LAMPRECHT, B, ZIMBER-STROBL, U
Published in Oncogene (14.04.2011)
Published in Oncogene (14.04.2011)
Get full text
Journal Article
COPANLISIB IN PATIENTS WITH RELAPSED OR REFRACTORY INDOLENT B‐CELL LYMPHOMA (CHRONOS‐1)
Dreyling, M., Santoro, A., Mollica, L., Leppä, S., Follows, G.A., Lenz, G., Kim, W., Nagler, A., Panayiotidis, P., Demeter, J., Özcan, M., Kosinova, M., Bouabdallah, K., Morschhauser, F., Stevens, D.A., Trevarthen, D., Giurescu, M., Liu, L., Koechert, K., Peña, C., Cupit, L., Yin, S., Hiemeyer, F., Garcia‐Vargas, J., Childs, B.H., Zinzani, P.
Published in Hematological oncology (01.06.2017)
Published in Hematological oncology (01.06.2017)
Get full text
Journal Article
PD-003 Analysis of single-nucleotide polymorphisms (SNPs) in the phase 3 CORRECT trial of regorafenib vs placebo in patients with metastatic colorectal cancer (mCRC)
Lambrechts, D., Koechert, K., Schulz, A., Vonk, R., Rutstein, M., Kobina, S., Grothey, A., Van Cutsem, E., Teufel, M.
Published in Annals of oncology (01.06.2016)
Published in Annals of oncology (01.06.2016)
Get full text
Journal Article
67PPI3K inhibition and modulation of immune and tumor microenvironment markers by copanlisib in patients with non-Hodgkin's lymphoma or advanced solid tumors
Awada, A H, Morschhauser, F, Machiels, J-P, Salles, G, Rottey, S, Rule, S, Cunningham, D, Peyrade, F, Fruchart, C, Arkenau, H-T, Genvresse, I, Koechert, K, Cisternas, G, Granvil, C, Pena, C, Liu, L
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
The IL-15 cytokine system provides growth and survival signals in Hodgkin lymphoma and enhances the inflammatory phenotype of HRS cells
Ullrich, K, Blumenthal-Barby, F, Lamprecht, B, Köchert, K, Lenze, D, Hummel, M, Mathas, S, Dörken, B, Janz, M
Published in Leukemia (01.05.2015)
Published in Leukemia (01.05.2015)
Get full text
Journal Article
Serum glucocorticoid-regulated kinase 1 ( ) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells
FAGERLI, U.-M, ULLRICH, K, SHAUGHNESSY, J. D, MATHAS, S, SUNDAN, A, BARGOU, R. C, DÖRKEN, B, BØRSET, M, JANZ, M, STÜHMER, T, HOLIEN, T, KÖCHERT, K, HOLT, R. U, BRULAND, O, CHATTERJEE, M, NOGAI, H, LENZ, G
Published in Oncogene (14.07.2011)
Published in Oncogene (14.07.2011)
Get full text
Journal Article